Steven Sherman - Sep 21, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
CEO & Chairman, Director
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Stock symbol
EKSO
Transactions as of
Sep 21, 2022
Transactions value $
-$10,553
Form type
4
Date filed
9/26/2022, 07:20 PM
Previous filing
Aug 23, 2022
Next filing
Oct 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Options Exercise $0 +15.6K +2.3% $0.00 695K Sep 21, 2022 Direct
transaction EKSO Common Stock Sale -$10.6K -6.04K -0.87% $1.75* 689K Sep 22, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EKSO Restricted Stock Units Options Exercise $0 -15.6K -20% $0.00 62.4K Sep 21, 2022 Common Stock 15.6K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on September 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the eighth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.
F2 The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.70 to $1.80, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.
F3 The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
F4 The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The eighth installment of RSUs vested on September 22, 2022 and were delivered to the Reporting Person upon settlement.